Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder
that affects an estimated 4 to 6 million people worldwide (1). In Denmark, the
prevalence of ADPKD has been estimated to be one per 1000 people, and it
accounts for approximately 8% of patients who are on renal replacement therapy
(RRT) (2,3). ADPKD is a genetically heterogeneous disease with mutations in two
genes, PKD1 andPKD2, which accounts for 85 and 15% of cases, respectively
(4,5).
An Overview of Polycystic Kidney Disease Treatment
There is no cure for polycystic kidney disease. Therefore, treatingpolycystic
kidney disease involves reducing symptoms and complications of the disease,
while improving the quality of life.
Specific treatment options vary based on the particular symptoms and their
severity. Some of the treatment methods used for polycystic kidney disease
include:
Medicine and surgery, to reduce pain
Antibiotics, to treat infections
Dialysis, to replace the function of failed kidneys
Kidney transplantation.
没有评论:
发表评论